Freshfields advised the Special Committee of the Board of Directors of Astra Space, Inc. on the successful closing of the company’s all-cash take-private transaction. Astra Space,...
You must be a Standard 1 Year member to access this content.
Freshfields’ Litigation Team successfully represented Sumitovant Biopharma Limited. A shareholder’s attempt to challenge a $2.9 billion take-private merger between Sumitovant Biopharma Limited (Sumitovant, formerly known as...
You must be a Standard 1 Year member to access this content.
Davis Polk represented the underwriters, Cooley represented Arlo and its officers and directors, and Wilson Sonsini represented Netgear. In the California state and federal court securities...
You must be a Standard 1 Year member to access this content.
Freshfields advised Zymergen Inc. (Nasdaq: ZY) on the deal, while Ropes & Gray advised Ginkgo Bioworks. Zymergen Inc. (Nasdaq: ZY), a biotechnology company that uses a...
You must be a Standard 1 Year member to access this content.
Freshfields served as issuer’s counsel to Zymergen Inc. The IPO values the company in excess of $4 billion. The company sold $575 million of shares of...
You must be a Standard 1 Year member to access this content.
